Renal Clinical Trial - To Compare the Pharmacokinetics of Avanafil in

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05568966` - Collection of Blood Samples for New Diagnostic Devices 2	N/A
Completed	`NCT00423254` - Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.	Phase 1
Completed	`NCT00972205` - Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT05568966 - Collection of Blood Samples for New Diagnostic Devices 2

N/A

Completed

NCT00423254 - Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Phase 1

Completed

NCT00972205 - Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01054261
Study type	Interventional
Source	VIVUS, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	January 2010
Completion date	February 2010

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms